FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philip Norman

Research Profile

Disorders

Living Beings

Pollen

Chemicals & Drugs

Physiology

Histamine Release

Procedures

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philip Norman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Philip S Norman
Sublingual swallow immunotherapy in the new world.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(5):405-6.
2004: David B K Golden; Anne Kagey-Sobotka; Philip S Norman; Robert G Hamilton; Lawrence M Lichtenstein
Outcomes of allergy to insect stings in children, with and without venom immunotherapy.
The New England journal of medicine 2004;351(7):668-74.
2004: Philip S Norman
Immunotherapy: 1999-2004.
The Journal of allergy and clinical immunology 2004;113(6):1013-23; quiz 1024.
2002: Philip S Norman; N FRANKLIN ADKINSON
Memorial. Thomas E. Van Metre, Jr. 1923-1996.
Transactions of the American Clinical and Climatological Association 2002;113():lvii-lix.
2001: David B K Golden; Anne Kagey-Sobotka; Philip S Norman; Robert G Hamilton; Lawrence M Lichtenstein
Insect sting allergy with negative venom skin test responses.
The Journal of allergy and clinical immunology 2001;107(5):897-901.
1998: J Bousquet; R Lockey; H J Malling; E Alvarez-Cuesta; G W Canonica; M D Chapman; Peter S Creticos; J M Dayer; S R Durham; P Demoly; R J Goldstein; T Ishikawa; K Ito; D Kraft; P H Lambert; H Løwenstein; U Müller; Philip S Norman; R E Reisman; R Valenta; Erkka Valovirta; H Yssel
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1998;81(5 Pt 1):401-5.
1998: Philip S Norman
Immunotherapy: past and present.
The Journal of allergy and clinical immunology 1998;102(1):1-10.
1998: Gregory V Marcotte; CM Braun; Philip S Norman; C F Nicodemus; Anne Kagey-Sobotka; Lawrence M Lichtenstein; David Essayan
Effects of peptide therapy on ex vivo T-cell responses.
The Journal of allergy and clinical immunology 1998;101(4 Pt 1):506-13.
1998: Beth L Laube; A M Edwards; Richard N. Dalby; Peter S Creticos; Philip S Norman
The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma.
The Journal of allergy and clinical immunology 1998;101(4 Pt 1):475-83.
1997: Philip S Norman; A B Kay; S T Holgate
Notice of duplicate publication.
The Journal of allergy and clinical immunology 1997;100(5):719-20.
1997: Philip S Norman; A B Kay; S T Holgate
Notice of duplicate publication.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1997;27(11):1356.
1997: Robert M Naclerio; David Proud; B Moylan; S Balcer; LR Freidhoff; Anne Kagey-Sobotka; Lawrence M Lichtenstein; Peter S Creticos; Robert G Hamilton; Philip S Norman
A double-blind study of the discontinuation of ragweed immunotherapy.
The Journal of allergy and clinical immunology 1997;100(3):293-300.
1997: C Nicodemus; G Philip; N Jones; S Hirani; Philip S Norman
Integrated clinical experience with tolerogenic peptides.
International archives of allergy and immunology 1997;113(1-3):326-8.
1997: Philip S Norman; C F Nicodemus; Peter S Creticos; Robert A Wood; Peyton A Eggleston; Lawrence M Lichtenstein; Anne Kagey-Sobotka; D Proud
Clinical and immunologic effects of component peptides in Allervax Cat.
International archives of allergy and immunology 1997;113(1-3):224-6.
1997: S Baskar; Robert G Hamilton; Philip S Norman; A A Ansari
Grass immunotherapy induces inhibition of allergen-specific human peripheral blood mononuclear cell proliferation.
International archives of allergy and immunology 1997;112(2):184-90.
1997: Philip S Norman
Responses to T cell tolerogenic peptides.
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M 1997;(91):40-4.
1996: Philip S Norman; J L Ohman; A A Long; Peter S Creticos; M A Gefter; Z Shaked; Robert A Wood; Peyton A Eggleston; K B Hafner; P Rao; Lawrence M Lichtenstein; N H Jones; C F Nicodemus
Treatment of cat allergy with T-cell reactive peptides.
American journal of respiratory and critical care medicine 1996;154(6 Pt 1):1623-8.
1996: Philip S Norman
Is there a role for immunotherapy in the treatment of asthma? Yes.
American journal of respiratory and critical care medicine 1996;154(5):1225-6.
1996: SK Vaswani; R H Plack; Philip S Norman
Acute severe urticaria and angioedema leading to myocardial infarction.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1996;77(2):101-4.
1996: Peter S Creticos; C E Reed; Philip S Norman; J Khoury; N FRANKLIN ADKINSON; C R Buncher; W W Busse; Robert K Bush; JYOTHI GADDE; J T Li
Ragweed immunotherapy in adult asthma.
The New England journal of medicine 1996;334(8):501-6.
1996: Philip S Norman
Clinical experience with treatment of allergies with T cell epitope containing peptides.
Advances in experimental medicine and biology 1996;409():457-61.
1996: Philip S Norman
Current status of immunotherapy for allergies and anaphylactic reactions.
Advances in internal medicine 1996;41():681-713.
1995: Peter S Creticos; J Burk; L Smith; R Comp; Philip S Norman; S Findlay
The use of twice daily nedocromil sodium in the treatment of asthma.
The Journal of allergy and clinical immunology 1995;95(4):829-36.
1994: Philip S Norman
WHO-IUIS International Standards: advantages of these extracts.
Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt für Sera und Impfstoffe) zu Frankfurt a.M 1994;(87):59-64.
1993: Philip S Norman
Modern concepts of immunotherapy.
Current opinion in immunology 1993;5(6):968-73.
1993: Robert M Naclerio; N FRANKLIN ADKINSON; Peter S Creticos; Fuad M Baroody; Robert G Hamilton; Philip S Norman
Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies.
The Journal of allergy and clinical immunology 1993;92(5):717-21.
1993: Philip S Norman
Therapeutic potential of peptides in allergic disease.
Annals of allergy 1993;71(3):330-3.
1993: E N Charlesworth; Anne Kagey-Sobotka; Philip S Norman; Lawrence M Lichtenstein; Frans Heeman
Cutaneous late-phase response in food-allergic children and adolescents with atopic dermatitis.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1993;23(5):391-7.
1992: Philip S Norman; Peter S Creticos; R Tobey; David Proud; Anne Kagey-Sobotka; Deborah A Meyers; T Persson
Budesonide in grass pollen rhinitis.
Annals of allergy 1992;69(4):309-16.
1992: E N Charlesworth; W A Massey; Anne Kagey-Sobotka; Philip S Norman; Lawrence M Lichtenstein
Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge.
The Journal of pharmacology and experimental therapeutics 1992;262(3):964-70.
1992: A M Majchel; David Proud; LR Freidhoff; Peter S Creticos; Philip S Norman; Robert M Naclerio
The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
The Journal of allergy and clinical immunology 1992;90(1):85-91.
1992: Philip S Norman
Discovering allergens.
The Journal of allergy and clinical immunology 1992;89(5):923-4.
1992: Z K Peng; Robert M Naclerio; Philip S Norman; N FRANKLIN ADKINSON
Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy.
The Journal of allergy and clinical immunology 1992;89(2):519-29.
1992: Beth L Laube; Philip S Norman; G K Adams
The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma.
The Journal of allergy and clinical immunology 1992;89(2):510-8.
1991: M J Furin; Philip S Norman; Peter S Creticos; David Proud; Anne Kagey-Sobotka; Lawrence M Lichtenstein; Robert M Naclerio
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.
The Journal of allergy and clinical immunology 1991;88(1):27-32.
1991: O Iliopoulos; David Proud; N FRANKLIN ADKINSON; Peter S Creticos; Philip S Norman; Anne Kagey-Sobotka; Lawrence M Lichtenstein; Robert M Naclerio
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
The Journal of allergy and clinical immunology 1991;87(4):855-66.
1991: E N Charlesworth; Anne Kagey-Sobotka; Robert P Schleimer; Philip S Norman; Lawrence M Lichtenstein
Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(2):671-6.
1990: O Iliopoulos; David Proud; N FRANKLIN ADKINSON; Philip S Norman; Anne Kagey-Sobotka; Lawrence M Lichtenstein; Robert M Naclerio
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells.
The Journal of allergy and clinical immunology 1990;86(6 Pt 1):851-61.
1990: T E Van Metre; N FRANKLIN ADKINSON; Anne Kagey-Sobotka; Arouna P Khattignavong; DG Marsh; Philip S Norman; G L Rosenberg
Immunotherapy decreases skin sensitivity to ragweed extract: demonstration by midpoint skin test titration.
The Journal of allergy and clinical immunology 1990;86(4 Pt 1):587-8.
1990: Philip S Norman
Immunotherapy of IgE-mediated disease.
Hospital practice (Office ed.) 1990;25(4):81-6, 89-92.
1990: Philip S Norman; T E Van Metre
The safety of allergenic immunotherapy.
The Journal of allergy and clinical immunology 1990;85(2):522-5.
1990: Richard R. Rosenthal; Beth L Laube; D B Hood; Philip S Norman
Analysis of refractory period after exercise and eucapnic voluntary hyperventilation challenge.
The American review of respiratory disease 1990;141(2):368-72.
1990: Philip S Norman; Peter S Creticos; DG Marsh
Frequency of booster injections of allergoids.
The Journal of allergy and clinical immunology 1990;85(1 Pt 1):88-94.
1989: Fuad M Baroody; David Proud; Anne Kagey-Sobotka; L Freidhoff; Philip S Norman; Lawrence M Lichtenstein; Robert M Naclerio
The effects of H1 antihistamines on the early allergic response.
Annals of allergy 1989;63(6 Pt 2):551-5.
1989: A Reshef; Anne Kagey-Sobotka; N FRANKLIN ADKINSON; Lawrence M Lichtenstein; Philip S Norman
The pattern and kinetics in human skin of erythema and mediators during the acute and late-phase response (LPR).
The Journal of allergy and clinical immunology 1989;84(5 Pt 1):678-87.
1989: Philip S Norman
Safety of allergen immunotherapy.
The Journal of allergy and clinical immunology 1989;84(4 Pt 1):438-9.
1989: M Wachs; David Proud; Lawrence M Lichtenstein; Anne Kagey-Sobotka; Philip S Norman; Robert M Naclerio
Observations on the pathogenesis of nasal priming.
The Journal of allergy and clinical immunology 1989;84(4 Pt 1):492-501.
1989: Peter S Creticos; DG Marsh; David Proud; Anne Kagey-Sobotka; N FRANKLIN ADKINSON; L Friedhoff; Robert M Naclerio; Lawrence M Lichtenstein; Philip S Norman
Responses to ragweed-pollen nasal challenge before and after immunotherapy.
The Journal of allergy and clinical immunology 1989;84(2):197-205.
1989: Robert M Naclerio; David Proud; Anne Kagey-Sobotka; L Freidhoff; Philip S Norman; Lawrence M Lichtenstein
The effect of cetirizine on early allergic response.
The Laryngoscope 1989;99(6 Pt 1):596-9.
1989: M E Weiss; P Trent; R Fisher; Philip S Norman; W E Waterbury; N FRANKLIN ADKINSON
Rabbit F(ab')2 antihuman IgE is a universal skin test reagent in the evaluation of skin mast cell degranulation in vivo.
The Journal of allergy and clinical immunology 1989;83(6):1040-8.
1989: T E Van Metre; DG Marsh; N FRANKLIN ADKINSON; Anne Kagey-Sobotka; Arouna P Khattignavong; Philip S Norman; G L Rosenberg
Immunotherapy decreases skin sensitivity to cat extract.
The Journal of allergy and clinical immunology 1989;83(5):888-99.
1989: E N Charlesworth; Anne Kagey-Sobotka; Philip S Norman; Lawrence M Lichtenstein
Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction.
The Journal of allergy and clinical immunology 1989;83(5):905-12.
1989: E N Charlesworth; A F Hood; N A Soter; Anne Kagey-Sobotka; Philip S Norman; Lawrence M Lichtenstein
Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.
The Journal of clinical investigation 1989;83(5):1519-26.
1988: T E Van Metre; DG Marsh; N FRANKLIN ADKINSON; Anne Kagey-Sobotka; Arouna P Khattignavong; Philip S Norman; G L Rosenberg
Immunotherapy for cat asthma.
The Journal of allergy and clinical immunology 1988;82(6):1055-68.
1988: O Iliopoulos; D Proud; Philip S Norman; L M Lichtenstein; A Kagey-Sobotka; R M Naclerio
Nasal challenge with cold, dry air induces a late-phase reaction.
The American review of respiratory disease 1988;138(2):400-5.
1988: M M Pienkowski; N FRANKLIN ADKINSON; M Plaut; Philip S Norman; Lawrence M Lichtenstein
Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses.
The Journal of allergy and clinical immunology 1988;82(1):95-100.
1988: Beth L Laube; Jonathan M Links; Henry N Wagner; Philip S Norman; D W Koller; N D LaFrance; G K Adams
Simplified assessment of fine aerosol distribution in human airways.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(6):1057-65.
1988: Philip S Norman
Immunotherapy for nasal allergy.
The Journal of allergy and clinical immunology 1988;81(5 Pt 2):992-6.
1988: Alkis Togias; Robert M Naclerio; David Proud; U Pipkorn; Rebecca Bascom; O Iliopoulos; Anne Kagey-Sobotka; Philip S Norman; Lawrence M Lichtenstein
Studies on the allergic and nonallergic nasal inflammation.
The Journal of allergy and clinical immunology 1988;81(5 Pt 1):782-90.
1988: Alkis Togias; David Proud; Lawrence M Lichtenstein; G K Adams; Philip S Norman; Anne Kagey-Sobotka; Robert M Naclerio
The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air.
The American review of respiratory disease 1988;137(3):625-9.
1987: Robert M Naclerio; Anne Kagey-Sobotka; Lawrence M Lichtenstein; Alkis Togias; O Iliopoulos; U Pipkorn; Rebecca Bascom; Philip S Norman; David Proud
Observations on nasal late phase reactions.
Immunological investigations 1987;16(8):649-85.
1987: Peter S Creticos; Philip S Norman
Immunotherapy with allergens.
JAMA : the journal of the American Medical Association 1987;258(20):2874-80.
1987: P Lind; Philip S Norman; M Newton; Henning Løwenstein; B Schwartz
The prevalence of indoor allergens in the Baltimore area: house dust-mite and animal-dander antigens measured by immunochemical techniques.
The Journal of allergy and clinical immunology 1987;80(4):541-7.
1987: U Pipkorn; G Granerus; D Proud; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein; R M Naclerio
The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction.
Allergy 1987;42(7):496-501.
1987: U Pipkorn; David Proud; Lawrence M Lichtenstein; Robert P Schleimer; Stephen P Peters; N FRANKLIN ADKINSON; Anne Kagey-Sobotka; Philip S Norman; Robert M Naclerio
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
The Journal of clinical investigation 1987;80(4):957-61.
1987: U Pipkorn; D Proud; L M Lichtenstein; A Kagey-Sobotka; Philip S Norman; R M Naclerio
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
The New England journal of medicine 1987;316(24):1506-10.
1987: Alkis Togias; D Proud; A Kagey-Sobotka; Philip S Norman; L Lichtenstein; R Naclerio
The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine.
The Journal of allergy and clinical immunology 1987;79(4):599-604.
1987: Philip S Norman
Fatal misadventures.
The Journal of allergy and clinical immunology 1987;79(4):572-3.
1987: M S Brown; S P Peters; N FRANKLIN ADKINSON; D Proud; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein; R M Naclerio
Arachidonic acid metabolites during nasal challenge.
Archives of otolaryngology--head & neck surgery 1987;113(2):179-83.
1986: Peter S Creticos; Philip S Norman
Why standardized extracts are necessary.
Clinical reviews in allergy 1986;4(4):355-61.
1986: R M Naclerio; Peter S Creticos; Philip S Norman; L M Lichtenstein
Mediator release after nasal airway challenge with allergen.
The American review of respiratory disease 1986;134(5):1102.
1986: T P King; Philip S Norman
Standardized extracts, weeds.
Clinical reviews in allergy 1986;4(4):425-33.
1986: R M Naclerio; D Bartenfelder; D Proud; A G Togias; Deborah A Meyers; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein
Theophylline reduces histamine release during pollen-induced rhinitis.
The Journal of allergy and clinical immunology 1986;78(5 Pt 1):874-6.
1986: C R Baumgarten; R C Nichols; R M Naclerio; L M Lichtenstein; Philip S Norman; D Proud
Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(3):977-82.
1986: T E Van Metre; DG Marsh; N FRANKLIN ADKINSON; J E Fish; Anne Kagey-Sobotka; Philip S Norman; E B Radden; G L Rosenberg
Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma.
The Journal of allergy and clinical immunology 1986;78(1 Pt 1):62-75.
1986: A G Togias; R M Naclerio; S P Peters; I Nimmagadda; D Proud; A Kagey-Sobotka; N FRANKLIN ADKINSON; Philip S Norman; L M Lichtenstein
Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air.
The American review of respiratory disease 1986;133(6):1133-7.
1986: Beth L Laube; D L Swift; Henry N Wagner; Philip S Norman; G K Adams
The effect of bronchial obstruction on central airway deposition of a saline aerosol in patients with asthma.
The American review of respiratory disease 1986;133(5):740-3.
1986: J E Fish; Philip S Norman
Effects of the calcium channel blocker, verapamil, on asthmatic airway responses to muscarinic, histaminergic, and allergenic stimuli.
The American review of respiratory disease 1986;133(5):730-4.
1986: J A Warner; M M Pienkowski; M Plaut; Philip S Norman; Lawrence M Lichtenstein
Identification of histamine releasing factor(s) in the late phase of cutaneous IgE-mediated reactions.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(7):2583-7.
1986: Philip S Norman
Why standardized extracts?
The Journal of allergy and clinical immunology 1986;77(3):405-6.
1986: A G Togias; R M Naclerio; J Warner; D Proud; A Kagey-Sobotka; I Nimmagadda; Philip S Norman; L M Lichtenstein
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation.
JAMA : the journal of the American Medical Association 1986;255(2):225-9.
1986: C R Baumgarten; R M Naclerio; A G Togias; L M Lichtenstein; Philip S Norman; D Proud
Kininogens in nasal secretions after allergen challenge.
Advances in experimental medicine and biology 1986;198 Pt B():189-92.
1985: A Togias; Robert M Naclerio; D Proud; C Baumgarten; S Peters; Peter S Creticos; J Warner; A Kagey-Sobotka; N FRANKLIN ADKINSON; Philip S Norman
Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis.
The American journal of medicine 1985;79(6A):26-33.
1985: R M Naclerio; D Bartenfelder; D Proud; A G Togias; Deborah A Meyers; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein
Theophylline reduces the response to nasal challenge with antigen.
The American journal of medicine 1985;79(6A):43-7.
1985: Peter S Creticos; N FRANKLIN ADKINSON; A Kagey-Sobotka; D Proud; H L Meier; R M Naclerio; L M Lichtenstein; Philip S Norman
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
The Journal of clinical investigation 1985;76(6):2247-53.
1985: M M Pienkowski; Philip S Norman; L M Lichtenstein
Suppression of late-phase skin reactions by immunotherapy with ragweed extract.
The Journal of allergy and clinical immunology 1985;76(5):729-34.
1985: Beth L Laube; G K Adams; Philip S Norman; Richard R. Rosenthal
The effect of inspiratory flow rate regulation on nebulizer output and on human airway response to methacholine aerosol.
The Journal of allergy and clinical immunology 1985;76(5):708-13.
1985: A G Togias; R M Naclerio; D Proud; J E Fish; N FRANKLIN ADKINSON; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
The Journal of clinical investigation 1985;76(4):1375-81.
1985: Philip S Norman
Newer antihistaminic agents.
The Journal of allergy and clinical immunology 1985;76(2 Pt 2):366-8.
1985: Robert M Naclerio; D Proud; A G Togias; N FRANKLIN ADKINSON; Deborah A Meyers; A Kagey-Sobotka; M Plaut; Philip S Norman; Lawrence M Lichtenstein
Inflammatory mediators in late antigen-induced rhinitis.
The New England journal of medicine 1985;313(2):65-70.
1985: C R Baumgarten; A G Togias; R M Naclerio; L M Lichtenstein; Philip S Norman; D Proud
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.
The Journal of clinical investigation 1985;76(1):191-7.
1985: Philip S Norman
Allergic rhinitis.
The Journal of allergy and clinical immunology 1985;75(5):531-48.
1985: R M Naclerio; M Plaut; N FRANKLIN ADKINSON; Philip S Norman
Effect of seasonal ragweed exposure on immunoglobulin E antiragweed antibodies in cultures of peripheral mononuclear cells, plasma and nasal secretions.
International archives of allergy and applied immunology 1985;78(3):225-32.
1985: Philip S Norman
Immunotherapy--state of the art.
New England and regional allergy proceedings 1985;6(3):249-54.
1985: Philip S Norman
Role of immunotherapy in asthma.
Chest 1985;87(1 Suppl):62S-64S.
1985: Philip S Norman; Robert M Naclerio; Peter S Creticos; A Togias; Lawrence M Lichtenstein
Mediator release after allergic and physical nasal challenges.
International archives of allergy and applied immunology 1985;77(1-2):57-63.
1984: J E Fish; L S Jameson; A Albright; Philip S Norman
Modulation of the bronchomotor effects of chemical mediators by prostaglandin F2 alpha in asthmatic subjects.
The American review of respiratory disease 1984;130(4):571-4.
1984: Philip S Norman
Clinical evaluation and therapy of allergic rhinitis in adults.
Clinical reviews in allergy 1984;2(3):189-96.
1984: Peter S Creticos; S P Peters; N FRANKLIN ADKINSON; R M Naclerio; E C Hayes; Philip S Norman; L M Lichtenstein
Peptide leukotriene release after antigen challenge in patients sensitive to ragweed.
The New England journal of medicine 1984;310(25):1626-30.
1984: Ricki M Helm; M B Gauerke; H Baer; H Løwenstein; A Ford; D A Levy; Philip S Norman; J W Yunginger
Production and testing of an international reference standard of short ragweed pollen extract.
The Journal of allergy and clinical immunology 1984;73(6):790-800.
1984: Philip S Norman; T P King; J F Alexander; A Kagey-Sobotka; L M Lichtenstein
Immunologic responses to conjugates of antigen E in patients with ragweed hay fever.
The Journal of allergy and clinical immunology 1984;73(6):782-9.
1984: L M Lichtenstein; MARTIN VALENTINE; Philip S Norman
A reevaluation of immunotherapy for asthma.
The American review of respiratory disease 1984;129(5):657-9.
1984: Peter S Creticos; T E Van Metre; M R Mardiney; G L Rosenberg; Philip S Norman; N FRANKLIN ADKINSON
Dose response of IgE and IgG antibodies during ragweed immunotherapy.
The Journal of allergy and clinical immunology 1984;73(1 Pt 1):94-104.
1984: S P Peters; Peter S Creticos; R M Naclerio; R P Schleimer; Donald MacGlashan; N FRANKLIN ADKINSON; Philip S Norman; L M Lichtenstein
IgE-mediated leukotriene release in vitro and in vivo.
Transactions of the Association of American Physicians 1984;97():260-7.
1984: R M Naclerio; H L Meier; A Kagey-Sobotka; Philip S Norman; L M Lichtenstein
In vivo model for the evaluation of topical antiallergic medications.
Archives of otolaryngology (Chicago, Ill. : 1960) 1984;110(1):25-7.
1983: Philip S Norman; S P Peters
'Asthma' that cleared when patient coughed.
Hospital practice (Office ed.) 1983;18(11):51-4, 57.
1983: D Proud; A Togias; R M Naclerio; S A Crush; Philip S Norman; L M Lichtenstein
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.
The Journal of clinical investigation 1983;72(5):1678-85.
1983: Philip S Norman
The John Sheldon memorial lecture. Review of nasal therapy: update.
The Journal of allergy and clinical immunology 1983;72(5 Pt 1):421-32.
1983: R M Naclerio; H L Meier; A Kagey-Sobotka; N FRANKLIN ADKINSON; Deborah A Meyers; Philip S Norman; L M Lichtenstein
Mediator release after nasal airway challenge with allergen.
The American review of respiratory disease 1983;128(4):597-602.
1983: W M Parham; R H Shepard; Philip S Norman; J E Fish
Analysis of time course and magnitude of lung inflation effects on airway tone: relation to airway reactivity.
The American review of respiratory disease 1983;128(2):240-5.
1983: G L Rosenberg; Richard R. Rosenthal; Philip S Norman
Inhalation challenge with ragweed pollen in ragweed-sensitive asthmatics.
The Journal of allergy and clinical immunology 1983;71(3):302-10.
1983: J E Fish; H H Newball; Philip S Norman; V I Peterman
Novel effects of PGF2 alpha on airway function in asthmatic subjects.
Journal of applied physiology: respiratory, environmental and exercise physiology 1983;54(1):105-12.
1983: N FRANKLIN ADKINSON; Peter S Creticos; Philip S Norman; M R Mardiney; G L Rosenberg; Robert G Hamilton; T E Van Metre
Characteristics of human IgE antibody responses in vivo.
Monographs in allergy 1983;18():69-74.
1983: Philip S Norman
Regulatory control and standardization of allergenic extracts. Clinical methods of evaluation of extracts.
Arbeiten aus dem Paul-Ehrlich-Institut, dem Georg-Speyer-Haus und dem Ferdinand-Blum-Institut zu Frankfurt a.M 1983;(78):65-9.
1983: R M Naclerio; H L Meier; N FRANKLIN ADKINSON; A Kagey-Sobotka; Deborah A Meyers; Philip S Norman; L M Lichtenstein
In vivo demonstration of inflammatory mediator release following nasal challenge with antigen.
European journal of respiratory diseases. Supplement 1983;128 (Pt 1)():26-32.
1982: R Patterson; Philip S Norman; T Van Metre
Immunotherapy-immunomodulation.
JAMA : the journal of the American Medical Association 1982;248(20):2759-72.
1982: P C Turkeltaub; S C Rastogi; H Baer; M C Anderson; Philip S Norman
A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results.
The Journal of allergy and clinical immunology 1982;70(5):343-52.
1982: Philip S Norman; L M Lichtenstein; A Kagey-Sobotka; D G Marsh
Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
The Journal of allergy and clinical immunology 1982;70(4):248-60.
1982: M Chatham; Eugene R Bleecker; Philip L. Smith; Richard R. Rosenthal; P Mason; Philip S Norman
A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects.
The American review of respiratory disease 1982;126(2):235-40.
1982: M Chatham; Eugene R Bleecker; Philip S Norman; Philip L. Smith; P Mason
A screening test for airways reactivity. An abbreviated methacholine inhalation challenge.
Chest 1982;82(1):15-8.
1982: P C Turkeltaub; Philip S Norman; J D Johnson; S Crepea
Treatment of seasonal and perennial rhinitis with intranasal flunisolide.
Allergy 1982;37(5):303-11.
1982: DG Marsh; Deborah A Meyers; LR Freidhoff; E Ehrlich-Kautzky; M Roebber; Philip S Norman; S H Hsu; W B Bias
HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. II. Response after ragweed immunotherapy.
The Journal of experimental medicine 1982;155(5):1452-63.
1982: T E Van Metre; N FRANKLIN ADKINSON; F J Amodio; Anne Kagey-Sobotka; L M Lichtenstein; M R Mardiney; Philip S Norman; G L Rosenberg
A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever.
The Journal of allergy and clinical immunology 1982;69(2):181-93.
1982: Philip S Norman
Quality control of allergen extracts.
The Journal of allergy and clinical immunology 1982;69(1 Pt 1):1-2.
1982: Philip S Norman
Immunotherapy.
Progress in allergy 1982;32():318-46.
1981: Philip S Norman; L M Lichtenstein; D G Marsh
Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever.
The Journal of allergy and clinical immunology 1981;68(6):460-70.
1981: D G Marsh; Philip S Norman; M Roebber; L M Lichtenstein
Studies on allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps.
The Journal of allergy and clinical immunology 1981;68(6):449-59.
1981: Rabia Hussain; Philip S Norman; D G Marsh
Rapidly released allergens from short ragweed pollen. II. Identification and partial purification.
The Journal of allergy and clinical immunology 1981;67(3):217-22.
1981: Philip S Norman
Newer developments in immunotherapy for hay fever.
International archives of allergy and applied immunology 1981;66 Suppl 1():43-7.
1980: T E Van Metre; N FRANKLIN ADKINSON; F J Amodio; L M Lichtenstein; M R Mardiney; Philip S Norman; G L Rosenberg; A K Sobotka; MARTIN VALENTINE
A comparative study of the effectiveness of the Rinkel method and the current standard method of immunotherapy for ragweed pollen hay fever.
The Journal of allergy and clinical immunology 1980;66(6):500-13.
1980: Philip S Norman; KIMISHIGE ISHIZAKA; L M Lichtenstein; N FRANKLIN ADKINSON
Treatment of ragweed hay fever with urea-denatured antigen E.
The Journal of allergy and clinical immunology 1980;66(4):336-41.
1980: T E Van Metre; N FRANKLIN ADKINSON; L M Lichtenstein; M R Mardiney; Philip S Norman; G L Rosenberg; A K Sobotka; MARTIN VALENTINE
A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever.
The Journal of allergy and clinical immunology 1980;65(4):288-97.
1980: EJ Britt; B Cohen; H Menkes; Eugene R Bleecker; S Permitt; Richard R. Rosenthal; Philip S Norman
Airways reactivity and functional deterioration in relatives of COPD patients.
Chest 1980;77(2 Suppl):260-1.
1980: Philip S Norman
An overview of immunotherapy: implications for the future.
The Journal of allergy and clinical immunology 1980;65(2):87-96.
1980: B E Chipps; A K Sobotka; J P Sanders; K C Teets; Philip S Norman; L M Lichtenstein
Effect of theophylline and terbutaline on immediate skin tests.
The Journal of allergy and clinical immunology 1980;65(1):61-4.
1979: Eugene R Bleecker; Richard R. Rosenthal; H A Menkes; Philip S Norman; S Permutt
Physiologic effects of inhaled histamine in asthma: reversible changes in pulmonary mechanics and total lung capacity.
The Journal of allergy and clinical immunology 1979;64(6 pt 2):597-602.
1979: Richard R. Rosenthal; Eugene R Bleecker; Beth L Laube; Philip S Norman; S Permutt
Effect of environmental antigen on cholinergic hyperreactivity.
Chest 1979;75(2 Suppl):228-9.
1979: D W Kordansky; Richard R. Rosenthal; Philip S Norman
The effect of vitamin C on antigen-induced bronchospasm.
The Journal of allergy and clinical immunology 1979;63(1):61-4.
1978: Philip S Norman; D G Marsh
Human serum albumin and Tween 80 as stabilizers of allergen solutions.
The Journal of allergy and clinical immunology 1978;62(5):314-9.
1978: Philip S Norman; C W Biermann; O L Frick; L L Henderson; J P McGovern; H C Mansman; P P VanArsdel
Physician manpower in allergy and immunology.
The Journal of allergy and clinical immunology 1978;62(1):61-6.
1978: Philip S Norman; L M Lichtenstein
Comparisons of alum-precipitated and unprecipitated aqueous ragweed pollen extracts in the treatment of hay fever.
The Journal of allergy and clinical immunology 1978;61(6):384-9.
1978: Philip S Norman; L M Lichtenstein
The clinical and immunologic specificity of immunotherapy.
The Journal of allergy and clinical immunology 1978;61(6):370-7.
1978: Philip S Norman
Bronchial reactivity and immunotherapy.
The Journal of allergy and clinical immunology 1978;61(5):281-2.
1978: D Kordansky; N FRANKLIN ADKINSON; Philip S Norman; Richard R. Rosenthal
Asthma improved by nonsteroidal anti-inflammatory drugs.
Annals of internal medicine 1978;88(4):508-11.
1978: Philip S Norman
A review of immunotherapy.
Allergy 1978;33(2):62-70.
1978: Philip S Norman
The rationale for immunotherapy in respiratory allergies.
Transactions of the American Clinical and Climatological Association 1978;89():119-29.
1977: C A Bruce; Philip S Norman; Richard R. Rosenthal; L M Lichtenstein
The role of ragweed pollen in autumnal asthma.
The Journal of allergy and clinical immunology 1977;59(6):449-59.
1977: Richard R. Rosenthal; Philip S Norman; W R Summer; S Permutt
Role of the parasympathetic system in antigen-induced bronchospasm.
Journal of applied physiology: respiratory, environmental and exercise physiology 1977;42(4):600-6.
1977: J E Fish; Richard R. Rosenthal; W R Summer; H Menkes; Philip S Norman; S Permutt
The effect of atropine on acute antigen-mediated airway constriction in subjects with allergic asthma.
The American review of respiratory disease 1977;115(3):371-9.
1977: L G Belin; Philip S Norman
Diagnostic tests in the skin and serum of works sensitized to Bacillus subtilis enzymes.
Clinical allergy 1977;7(1):55-68.
1976: P C Turkeltaub; Philip S Norman; S Crepea
Treatment of ragweed hay fever with an intranasal spray containing fluinsolide, a new synthetic corticosteroid.
The Journal of allergy and clinical immunology 1976;58(5):597-606.
1976: C A Bruce; W B Bias; Philip S Norman; L M Lightenstein; D G Marsh
Studies of HLA antigen frequencies, IgE levels, and specific allergic sensitivities in patients having ragweed hayfever, with and without asthma.
Clinical and experimental immunology 1976;25(1):67-72.
1976: Philip S Norman
Presidential address. The advance of science and the professional society.
The Journal of allergy and clinical immunology 1976;57(6):513-7.
1976: J E Fish; Richard R. Rosenthal; G Batra; H Menkes; W Summer; S Permutt; Philip S Norman
Airway responses to methacholine in allergic and nonallergic subjects.
The American review of respiratory disease 1976;113(5):579-86.
1976: T A Platts-Mills; R K von Maur; KIMISHIGE ISHIZAKA; Philip S Norman; L M Lichtenstein
IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.
The Journal of clinical investigation 1976;57(4):1041-50.
1975: Richard R. Rosenthal; Philip S Norman; W R Summer
Bronchoprovocation: effect on priming and desensitization phenomenon in the lung.
The Journal of allergy and clinical immunology 1975;56(5):338-46.
1975: C A Bruce; Richard R. Rosenthal; L M Lichtenstein; Philip S Norman
Quantitative inhalation bronchial challenge in ragweed hay fevery patients: a comparison with ragweed-allergic asthmatics.
The Journal of allergy and clinical immunology 1975;56(5):331-7.
1975: T P King; L Kochoumian; KIMISHIGE ISHIZAKA; L M Lichtenstein; Philip S Norman
Immunochemical studies of dextran coupled ragweed pollen allergen, antigen E.
Archives of biochemistry and biophysics 1975;169(2):464-73.
1975: Richard R. Rosenthal; K P Wang; Philip S Norman
Letter: "All that is asthma does not wheeze".
The New England journal of medicine 1975;292(7):372.
1975: Philip S Norman
Immunotherapy (desensitization) in allergic disease.
Annual review of medicine 1975;26():337-44.
1975: Richard R. Rosenthal; C A Bruce; L M Lichtenstein; Philip S Norman
The role of inhalation challenge.
International archives of allergy and applied immunology 1975;49(1-2):89-94.
1974: H Baer; C J Maloney; Philip S Norman; D G Marsh
The potency and Group I antigen content of six commercially prepared grass pollen extracts.
The Journal of allergy and clinical immunology 1974;54(3):157-64.
1974: C A Bruce; Richard R. Rosenthal; L M Lichtenstein; Philip S Norman
Diagnostic tests in ragweed-allergic asthma. A comparison of direct skin tests, leukocyte histamine release, and quantitative bronchial challenge.
The Journal of allergy and clinical immunology 1974;53(4):230-9.
1974: T P King; Philip S Norman; N Tao
Chemical modifications of the major allergen of ragweed pollen, antigen E.
Immunochemistry 1974;11(2):83-92.
1974: Philip S Norman
Specific therapy in allergy. Pro (with reservations).
The Medical clinics of North America 1974;58(1):111-25.
1973: Philip S Norman; L M Lichtenstein; KIMISHIGE ISHIZAKA
Diagnostic tests in ragweed hay fever. A comparison of direct skin tests, IgE antibody measurements, and basophil histamine release.
The Journal of allergy and clinical immunology 1973;52(4):210-24.
1973: Philip S Norman; L M Lichtenstein
Capacity of purified antigens and whole pollen extracts to release histamine from leukocytes of hay fever patients.
The Journal of allergy and clinical immunology 1973;52(2):94-104.
1973: Philip S Norman
Schwannoma of the nasal cavity.
Archives of otolaryngology (Chicago, Ill. : 1960) 1973;97(5):431.
1973: P Steinberg; Philip S Norman
Mechanism of action of mineral oil adjuvants. I. Conditions influencing the in vitro stability of water-in-oil emulsions.
The Journal of allergy and clinical immunology 1973;51(4):238-44.
1973: L M Lichtenstein; KIMISHIGE ISHIZAKA; Philip S Norman; A K Sobotka; B M Hill
IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy.
The Journal of clinical investigation 1973;52(2):472-82.
1972: T Kawai; D G Marsh; L M Lichtenstein; Philip S Norman
The allergens responsible for house dust allergy.
The Journal of allergy and clinical immunology 1972;50(2):117-27.
1972: Philip S Norman; W L Winkenwerder; L M Lichtenstein
Trials of alum-precipitated pollen extracts in the treatment of hay fever.
The Journal of allergy and clinical immunology 1972;50(1):31-44.
1972: D G Marsh; L M Lichtenstein; Philip S Norman
Induction of IgE-mediated immediate hypersensitivity to group I rye grass pollen allergen and allergoids in non-allergic man.
Immunology 1972;22(6):1013-28.
1971: L M Lichtenstein; Philip S Norman; W L Winkenwerder
A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies.
Annals of internal medicine 1971;75(5):663-71.
1971: Philip S Norman; W L Winkenwerder; L M Lichtenstein
Maintenance immunotherapy in ragweed hay fever. Booster injections at six week intervals.
The Journal of allergy 1971;47(5):273-82.
1970: A Turk; L M Lichtenstein; Philip S Norman
Nasal secretory antibody to inhalant allergens in allergic and non-allergic patients.
Immunology 1970;19(1):85-95.
1970: H Baer; H Godfrey; C J Maloney; Philip S Norman; L M Lichtenstein
The potency and antigen E content of commercially prepared ragweed extracts.
The Journal of allergy 1970;45(6):347-54.
1969: Philip S Norman
A rational approach to desensitization.
The Journal of allergy 1969;44(3):129-45.
1969: L M Lichtenstein; Philip S Norman
Human allergic reactions.
The American journal of medicine 1969;46(2):163-73.
1969: J L Chen; N Moore; Philip S Norman; T E Van Metre
Disodium cromoglycate, a new compound for the prevention of exacerbations of asthma.
The Journal of allergy 1969;43(2):89-100.
1968: Philip S Norman; W L Winkenwerder; L M Lichtenstein
Immunotherapy of hay fever with ragweed antigen E: comparisons with whole pollen extract and placebos.
The Journal of allergy 1968;42(2):93-108.
1968: L M Lichtenstein; Philip S Norman; W L Winkenwerder
Clinical and in vitro studies on the role of immunotherapy in ragweed hay fever.
The American journal of medicine 1968;44(4):514-24.
1968: L M Lichtenstein; Philip S Norman; W L Winkenwerder
Antibody response following immunotherapy in ragweed hay fever: Allpyral vs. whole ragweed extract.
The Journal of allergy 1968;41(1):49-57.
1967: B F Agbayani; Philip S Norman; W L Winkenwerder
The incidence of allergic aspergillosis in chronic asthma.
The Journal of allergy 1967;40(6):319-26.
1967: T P King; Philip S Norman; L M Lichtenstein
Studies on ragweed pollen allergens. V.
Annals of allergy 1967;25(10):541-53.
1967: L M Lichtenstein; Philip S Norman; J T Connell
Comparison between skin-sensitizing antibody titers and leukocyte sensitivity measurements as an index of the severity of ragweed hay fever.
The Journal of allergy 1967;40(3):160-7.
1967: Philip S Norman; W L Winkenwerder; B F Agbayani; Claude J Migeon
Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever.
The Journal of allergy 1967;40(1):57-61.
1967: T P King; Philip S Norman; L M Lichtenstein
Isolation and characterization of allergens from ragweed pollen. IV.
Biochemistry 1967;6(7):1992-2000.
1967: Philip S Norman; W L Winkenwerder; BURTON D'LUGOFF; J Tignall
Controlled evaluations of repository therapy in ragweed hay fever.
The Journal of allergy 1967;39(2):82-92.
1966: Philip S Norman; W L Winkenwerder; G W Murgatroyd; J W Parsons
Evidence for the local action of intranasal dexamethasone aerosols in the suppression of hay fever symptoms.
The Journal of allergy 1966;38(2):93-9.
1966: R S Holzman; Philip S Norman
The effect of alum concentration on the repository and adjuvant properties of alum-precipitated antigens.
The Journal of allergy 1966;38(2):65-73.
1966: Lawrence M Lichtenstein; Philip S Norman; W L Winkenwerder; A G Osler
In vitro studies of human ragweed allergy: changes in cellular and humoral activity associated with specific desensitization.
The Journal of clinical investigation 1966;45(7):1126-36.
1966: J R Pomeranz; Philip S Norman
Concomitant anaphylactic sensitization and contact unresponsiveness following the infusion or feeding of picryl chloride to guinea pigs.
The Journal of experimental medicine 1966;124(1):69-80.
1966: Philip S Norman
Treatment of allergic rhinitis.
Modern treatment 1966;3(4):881-90.
1966: Philip S Norman
Antiplasmins.
Federation proceedings 1966;25(1):63-7.
1965: Philip S Norman; W L WINKENWERDER
SUPPRESSION OF HAY FEVER SYMPTOMS WITH INTRANASAL DEXAMETHASONE AEROSOL.
The Journal of allergy 1965;36():284-92.
1964: Philip S Norman; E YANAGISAWA
MUCOCELE OF SPHENOID SINUS. REPORT OF A CASE.
Archives of otolaryngology (Chicago, Ill. : 1960) 1964;79():646-52.
1964: T P KING; Philip S Norman; J T CONNELL
ISOLATION AND CHARACTERIZATION OF ALLERGENS FROM RAGWEED POLLEN. II.
Biochemistry 1964;3():458-68.
1963: E W SMITH; K GOSHI; Philip S Norman; L E CLUFF
STUDIES ON THE PATHOGENESIS OF STAPHYLOCOCCAL INFECTION. VIII. THE HUMAN CUTANEOUS REACTION TO INJECTION OF ALPHA HEMOLYSIN.
Bulletin of the Johns Hopkins Hospital 1963;113():247-60.
1963: K GOSHI; E W SMITH; L E CLUFF; Philip S Norman
STUDIES ON THE PATHOGENESIS OF STAPHYLOCOCCAL INFECTION. VII. CHARACTERIZATION OF THE DERMAL REACTION TO PURIFIED ALPHA HEMOLYSIN IN NORMAL AND IMMUNE ANIMALS.
Bulletin of the Johns Hopkins Hospital 1963;113():183-201.
1963: K GOSHI; L E CLUFF; Philip S Norman
Studies on the pathogenesis of staphylococcal infection. VI. Mechanism of immunity conferred by anti-alpha hemolysin.
Bulletin of the Johns Hopkins Hospital 1963;112():31-47.
1963: K GOSHI; L E CLUFF; Philip S Norman
Studies on the pathogenesis of staphylococcal infection. V. Purification and characterization of staphylococcal alpha hemolysin.
Bulletin of the Johns Hopkins Hospital 1963;112():15-30.
1962: F R FEKETY; Philip S Norman; L E CLUFF
The treatment of gram-negative bacillary infections with colistin. The toxicity and efficacy of large doses in forty-eight patients.
Annals of internal medicine 1962;57():214-29.
1962: T P KING; Philip S Norman
Isolation studies of allergens from regweed pollen.
Biochemistry 1962;1():709-20.
1962: Philip S Norman
Antibiotics in chronic bronchitis and bronchiectasis.
Journal of chronic diseases 1962;15():719-27.
1962: Philip S Norman; E W HOOK; R G PETERSDORF; L E CLUFF; M P GODFREY; A H LEVY
Long-term tetracycline treatment of chronic bronchitis.
JAMA : the journal of the American Medical Association 1962;179():833-40.
1960: Philip S Norman
Some aspects of the chemistry of plasmin and its inhibitors.
The American journal of cardiology 1960;6():390-8.
1960: Philip S Norman; J G RAY; P S BRACHMAN; S A PLOTKIN; Joseph S Pagano
Serologic testing for anthrax antibodies in workers in a goat hair processing mill.
American journal of hygiene 1960;72():32-7.
1959: Philip S Norman; P J KADULL
The anti-inflammatory effect of buccal streptokinase-streptodornase; a controlled double-blind study.
Bulletin of the Johns Hopkins Hospital 1959;105(2):61-6.
1959: Philip S Norman; E W HOOK; R G PETERSDORF; L E CLUFF; M C GODFREY; J C RIBBLE; A H LEVY
The effect of long-term tetracycline therapy on chronic bronchitis. A preliminary report.
Antibiotics annual 1959;7():182-9.
1958: Philip S Norman; B M HILL
Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.
The Journal of experimental medicine 1958;108(5):639-49.
1958: Philip S Norman
Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.
The Journal of experimental medicine 1958;108(1):53-68.
1957: Philip S Norman
Effect of urea and methylamine on plasmin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;96(3):709-11.
1957: Philip S Norman
Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.
The Journal of experimental medicine 1957;106(3):423-37.